3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...
Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial inte...
By incorporating Sware's Res_Q platform, clients can enhance, streamline, and optimize the flow of content and data, effectively addressing the challenges ...
United Digestive now offers patients receiving a colonoscopy an enhanced screening by GI Genius™ intelligent endoscopy module. The GI Geniu...
This collaboration occurs in the wake of recent advancements from GERO, which sparked vigorous discussion among longevity experts in the scientific communi...
Etiometry, the leader in clinical decision-support software, announced today its IVCO2 Index™was cleared by the Food and Drug Administration for use ...
BLUEMOTH, a pioneer in consumer-first hearing wellness, announced the launch of a virtual destination that gives users the freedom to discover and sh...
The Synaptive MRI is a 0.5T system that was designed to overcome challenges such as accessibility in critical and acute cases like brain tumour and stroke,...
Within3 announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The com...
Grifols will apply artificial intelligence technologies, including large language models, to speed up the development of new biopharma therapeutics Agre...
Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design and development InstaDeep to opera...
InSilicoTrials, a leading provider of artificial intelligence (AI) and simulation tools for drug and medical device development, has embarked on a ...
Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that the companies have agreed ...
© 2024 Biopharma Boardroom. All Rights Reserved.
